Literature DB >> 21306196

Factors associated with the development of cytomegalovirus infection following solid organ transplantation.

Caspar da Cunha-Bang1, Søren S Sørensen, Martin Iversen, Henrik Sengeløv, Jens G Hillingsø, Allan Rasmussen, Svend A Mortensen, Zoe V Fox, Nikolai S Kirkby, Claus B Christiansen, Jens D Lundgren.   

Abstract

BACKGROUND: Infection with cytomegalovirus (CMV) remains a potentially serious complication in transplant patients. In this study we explored the risk factors for CMV infection in the 12 months following a solid organ transplantation (n = 242) in patients monitored for CMV infection from 2004 to 2007.
METHODS: CMV infection was defined as 2 consecutive quantifiable CMV-polymerase chain reaction (PCR) values or 1 measurement of >3000 copies/ml. Data describing pre- and post-transplantation variables were extracted from electronic health records. Time to CMV infection was investigated using Cox proportional hazards analysis.
RESULTS: Overall, 31% (75/242) of solid organ transplant patients developed CMV infection: 4/8 (50.0%) heart, 15/43 (34.9%) liver, 30/89 (33.7%) lung and 26/102 (25.5%) kidney transplant patients. The risk of CMV infection according to donor (D)/recipient (R) CMV serostatus (positive + or negative-) was highest for D+/R-(adjusted hazard ratio 2.6, 95% confidence interval 1.6-4.2) vs D+/R+, and was reduced for D-/R+(adjusted hazard ratio 0.2, 95% confidence interval 0.2-0.8) vs D+/R+.
CONCLUSION: Positive donor CMV-serostatus is a major risk factor for CMV-infection in CMV-na ve recipients, but also in recipients with positive CMV-serostatus. Conversely, if donor is CMV serostatus is negative, the risk of CMV infection is low, irrespective of recipients CMV-serostatus. These findings suggest poorer immune function towards donor-induced strains of CMV versus recipient own latent strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306196     DOI: 10.3109/00365548.2010.549836

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Successful multidisciplinary treatment of refractory cytomegalovirus infection after living donor liver transplantation using mixed lymphocyte reactions: report of a case.

Authors:  Kazuhisa Takeda; Yu Sawada; Takafumi Kumamoto; Ryusei Matsuyama; Yuka Tanaka; Hideki Ohdan; Itaru Endo
Journal:  Clin J Gastroenterol       Date:  2016-02-18

3.  Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?

Authors:  C Ekenberg; I P Lodding; N E Wareham; S S Sørensen; H Sengeløv; F Gustafsson; A Rasmussen; M Perch; J D Lundgren; M Helleberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-08       Impact factor: 3.267

Review 4.  Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.

Authors:  Federico Rea; Luciano Potena; Nizar Yonan; Florian Wagner; Fiorella Calabrese
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

5.  Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.

Authors:  Isabelle P Lodding; Amanda Mocroft; Caspar da Cunha Bang; Finn Gustafsson; Martin Iversen; Nikolai Kirkby; Michael Perch; Allan Rasmussen; Henrik Sengeløv; Søren S Sørensen; Jens D Lundgren
Journal:  Transplant Direct       Date:  2018-05-16

6.  Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation Sequencing.

Authors:  Isabelle P Lodding; Mette Jørgensen; Marc Bennedbæk; Nikolai Kirkby; Klaudia Naegele; Finn Gustafsson; Michael Perch; Allan Rasmussen; Henrik Sengeløv; Søren S Sørensen; Hans H Hirsch; Jens D Lundgren
Journal:  Open Forum Infect Dis       Date:  2021-09-04       Impact factor: 3.835

7.  Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections.

Authors:  I P Lodding; H Sengeløv; C da Cunha-Bang; M Iversen; A Rasmussen; F Gustafsson; J G Downing; J Grarup; N Kirkby; C M Frederiksen; A Mocroft; S S Sørensen; J D Lundgren
Journal:  EBioMedicine       Date:  2015-05-08       Impact factor: 8.143

8.  Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.

Authors:  I P Lodding; C da Cunha Bang; S S Sørensen; F Gustafsson; M Iversen; N Kirkby; M Perch; A Rasmussen; H Sengeløv; A Mocroft; J D Lundgren
Journal:  Open Forum Infect Dis       Date:  2018-04-17       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.